Skip to content

Role of Ayurvedic drugs (Panchatikta Ghrita Guggulu, Guduchyadi Kwatha and Manjishthadi Taila) in the Management of Eczema.

â??A Randomized Comparative Clinical Study to Evaluate the Efficacy of Panchatikta Ghrita Guggulu, Guduchyadi Kwatha and Manjishthadi Taila in the Management of Vicharchika W.S.R. to Eczema.â??

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025030
Enrollment
50
Registered
2020-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Panchatikta Ghrita Gugglu and Manjishthadi Taila: 25 patients will be administered trial drug Panchatikta Ghrita Guggulu 500 mg twice in a day orally, before meal in morning and evening

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to participate in the clinical trial. 2. Patients age between 18-70 years. 3. Patients of both sex male and female. 4. The patients having clinical signs and symptoms of Vicharchika (Eczema). 5. The Patients having complain less than 5 years duration.

Exclusion criteria

Exclusion criteria: 1. Patients below the age of 18 years and above 70 years. 2. Patients with Steroid and cytotoxic treatment.( >3 years) 3. Patients having concomitant illness like uncontrol HTN, uncontrol DM Type-2 and chronic Eczema. 4. Patients with evidence of malignancy. 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Changes in the Bahusrava symptom of Vicharchika (Eczema).Timepoint: 0th and 30th day

Secondary

MeasureTime frame
Changes in the objective parameters.Timepoint: 0th and 30th day

Countries

India

Contacts

Public ContactBharti Panchal

National Institute of Ayurveda, Jaipur

bhartipanchaljpr@gmail.com8385081794

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026